Tilray Medical Strengthens Global Medical Cannabis Supply Chain with Approval to Bring Critical EU-GMP Quality Testing In-House, Accelerating Product Release Across Regulated Global Markets
Go back to Tilray Medical Strengthens Global Medical Cannabis Supply Chain with Approval to Bring Critical EU-GMP Quality Testing In-House, Accelerating Product Release Across Regulated Global Markets| (NASDAQ: TLRY) | Delayed: 2.94 +0.02 (0.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.92 | 52 Week High | $ | |||
| Open | $2.90 | 52 Week Low | $ | |||
| Day High | $3.00 | P/E | N/A | |||
| Day Low | $2.87 | EPS | $ | |||
| Volume | 2,227,745 | |||||



